The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide.
about
Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptorNoladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissuesEther-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian speciesPresence and regulation of the endocannabinoid system in human dendritic cellsCharacterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamideEvidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cellsThe inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammationNeuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLĪ±) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus.The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors.The endocannabinoid system as a target for the treatment of neurodegenerative disease.The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells.Lipidomic metabolism analysis of the endogenous cannabinoid anandamide (N-arachidonylethanolamide)A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells.A methodology for radiolabeling of the endocannabinoid 2-arachidonoylglycerol (2-AG).Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown.Cannabinoids and neuroinflammation.Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerolPromising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotectionCOX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation.2-Arachidonoylglycerol (2-AG) membrane transport: history and outlookThe endocannabinoid system: a general view and latest additionsEndocannabinoids--at the crossroads between the gut microbiota and host metabolism.Critical enzymes involved in endocannabinoid metabolismEvidence for bidirectional endocannabinoid transport across cell membranesExpression and function of fatty acid amide hydrolase in prostate cancer.Monoglyceride lipase as an enzyme hydrolyzing 2-arachidonoylglycerol.The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of actionTherapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors.Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamideMechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol.An overview on the biochemistry of the cannabinoid system.Nutritional properties of dietary omega-3-enriched phospholipids.Candidate genes for cannabis use disorders: findings, challenges and directionsCannabinoids as therapeutic agents for ablating neuroinflammatory disease.The endocannabinoid system and sex steroid hormone-dependent cancers.Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood.Antihyperalgesic Activities of Endocannabinoids in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids.
P2860
Q28175607-312E0325-3372-41FC-9148-CAC6996B1460Q28208218-06FDC0A7-4F94-428F-87B3-56A985A4E099Q28208659-9AA01B7B-06E9-48A7-9258-F620D5BBF850Q28216698-7AB005AE-F9F8-408C-A4AD-8FBF157D2437Q28363051-71E6B656-4589-434B-BC51-816EC816CFFBQ28378272-32256269-3905-4802-AD4E-B3F3F17E554FQ28594581-F42047C0-F93E-4899-9806-D98C8810B4FFQ30493991-B8AB6865-BDBF-473F-888D-CF56282470DBQ33814030-0C1D2737-F46F-4217-A2BC-C28177296956Q33940288-779C23F0-A161-47A3-94E0-11545E78D8ABQ34098196-BE36F20C-4CB7-41BC-BDDD-01A1E70290D3Q34115272-F8A0E175-AAF1-4E23-9C9E-DD85C3FDE3DAQ34128351-DBA8CC00-0838-4FEE-8835-203B0021826DQ34282147-6CA738BA-BB52-4E43-9F3E-87017FDA3856Q34575024-58CB99CB-570A-484B-9F83-C4DADA5C196DQ34722934-3FFB6F27-A74A-4730-9271-2EBC6A0831F1Q34818110-59907042-0663-46CB-8939-AEC9511D2172Q35046205-A109870F-F198-4A5C-BAC9-69ADBF7EEC0EQ35048362-F84E1AB5-7B7E-4063-B905-561EB66344B6Q35499568-5E1048AF-07A3-4875-9A59-443E511245CBQ35593070-8072B4AC-28B5-40B3-915A-8DF50C0E97DDQ35594895-396862FA-A870-4742-82E0-8A1169FBEB75Q35639524-B61C77AF-B8E5-47D7-8BA4-34030FB5C705Q35871872-0EC26E53-FE97-4326-A908-44C8A9E2233FQ35924804-0CCF524D-F87F-46E7-BB08-BE9AD38DEB49Q36298487-EE6C67C1-0693-4BD0-8518-18B045B37896Q36901770-BFF069C9-E228-4A68-B086-93DF85C48BC9Q36916145-717B8C7C-D595-4D5B-A788-CB72E4023360Q36943243-37C1C9B5-8465-4C2E-806D-3FCC9D67D79FQ36957968-5E5BFAA9-16E7-4357-AB67-F6467AE2480AQ36961011-CF08E2CD-496D-44F1-9ECF-DC145984A0D9Q36968568-4A8DDA98-D750-4784-8D6F-F4452929B5C4Q36977733-5380FB24-DBA7-4DA4-8FF5-E8DA52DCB4C3Q37105403-704D3924-4779-4DCB-A91B-84D68A742753Q37245382-6C4ACE54-49D3-4102-9A62-5E5AEE553156Q37264965-E7059739-E4CF-410A-8841-F1BB5B9F1633Q37393042-9313B719-5684-4770-BB03-E34D2350FFE8Q37655918-69756CB8-C7D0-476D-A838-AAD7E892A3C6Q37710345-B70CC5AD-C95B-4CCB-99B2-6FC5BE900F12Q38185075-DEB9F85A-B042-4E04-8D72-8E2D92AA7A08
P2860
The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide.
description
1998 nĆ® lÅ«n-bĆ»n
@nan
1998幓ć®č«ę
@ja
1998幓č«ę
@yue
1998幓č«ę
@zh-hant
1998幓č«ę
@zh-hk
1998幓č«ę
@zh-mo
1998幓č«ę
@zh-tw
1998幓č®ŗę
@wuu
1998幓č®ŗę
@zh
1998幓č®ŗę
@zh-cn
name
The novel endogenous cannabino ...... : connections with anandamide.
@en
The novel endogenous cannabino ...... : connections with anandamide.
@nl
type
label
The novel endogenous cannabino ...... : connections with anandamide.
@en
The novel endogenous cannabino ...... : connections with anandamide.
@nl
prefLabel
The novel endogenous cannabino ...... : connections with anandamide.
@en
The novel endogenous cannabino ...... : connections with anandamide.
@nl
P2093
P2860
P921
P356
P1433
P1476
The novel endogenous cannabino ...... : connections with anandamide.
@en
P2093
L De Petrocellis
V Di Marzo
P2860
P356
10.1042/BJ3310015
P407
P478
331 ( Pt 1)
P577
1998-04-01T00:00:00Z